{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05199480",
            "orgStudyIdInfo": {
                "id": "HM20022776"
            },
            "organization": {
                "fullName": "Virginia Commonwealth University",
                "class": "OTHER"
            },
            "briefTitle": "Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health",
            "officialTitle": "Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health",
            "therapeuticArea": [
                "Other"
            ],
            "study": "understanding-the-impact-of-cartridge-based-electronic-cigarettes-and-generated-aerosols-on-cardiopulmonary-health"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-16",
            "studyFirstSubmitQcDate": "2022-01-05",
            "studyFirstPostDateStruct": {
                "date": "2022-01-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Virginia Commonwealth University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the user's health. The overall goal of this study is to evaluate the impact of e-cigarettes usage on user's cardiopulmonary health"
        },
        "conditionsModule": {
            "conditions": [
                "E-Cig Use"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 57,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "E-cigarette liquid type 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.",
                    "interventionNames": [
                        "Drug: Tobacco flavored liquid type 1"
                    ]
                },
                {
                    "label": "E-cigarettes liquid type 2",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will be instructed to use at least one study product daily in place of their own e-cigarettes during the intervention period.",
                    "interventionNames": [
                        "Drug: Tobacco flavored liquid type 2"
                    ]
                },
                {
                    "label": "No e-cigarettes",
                    "type": "NO_INTERVENTION",
                    "description": "No e-cigarette use"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Tobacco flavored liquid type 1",
                    "description": "A commercially available cartridge-based device with tobacco flavored liquid.",
                    "armGroupLabels": [
                        "E-cigarette liquid type 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tobacco flavored liquid type 2",
                    "description": "A commercially available cartridge-based device with tobacco flavored liquid.",
                    "armGroupLabels": [
                        "E-cigarettes liquid type 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Peak oxygen consumption (VO2 peak)",
                    "description": "Participants' peak oxygen consumption (VO2 peak) will be measured using a standardized exercise capacity test performed on a stationary bike.",
                    "timeFrame": "Change from baseline to 2 weeks"
                },
                {
                    "measure": "Change in Expiratory Volume",
                    "description": "Participants expiratory volume will be measured through spirometry using a pulmonary function device.",
                    "timeFrame": "Change from baseline to 2 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Skeletal muscle O2 utilization",
                    "description": "Assessment of skeletal muscle oxygen utilization using near-infrared spectroscopy through the ratio of O2 delivery and O2 extraction",
                    "timeFrame": "Change from baseline to 2 weeks"
                },
                {
                    "measure": "Change in Maximal microvascular dilation",
                    "description": "Participants' microvascular function (maximal dilation) will be measured using local thermal hyperemia.",
                    "timeFrame": "Change from baseline to 2 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nE-Cigarette group:\n\n* 21 years of age or older\n* Used e-cigarettes (\u22653 times/week for \u22653 months)\n\nNon e-cigarette group\n\n\u25cf 21 years of age or older\n\nExclusion Criteria:\n\n* 20 years old and younger\n* Use of cigarettes for 15 days or more in the past 60 days\n* Use of other tobacco products (cigars, hookah, smokeless) weekly or more frequently in the past 60 days\n* Use of marijuana or any illicit or prescription drugs for non-medical use weekly or more frequently in the past 60 days\n* Known allergy to propylene glycol or vegetable glycerin\n* Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, or cerebral diseases\n* Disorder or use of medication that affects cardiopulmonary health\n* Evidence of pregnancy or current nursing",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "21 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Paula Rodriguez Miguelez, PhD",
                    "role": "CONTACT",
                    "phone": "804-396-4498",
                    "email": "prodriguezmig@vcu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Paula Rodriguez Miguelez, PhD",
                    "affiliation": "Virginia Commonwealth University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Virginia Commonwealth University",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23298",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}